{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:35:56Z","timestamp":1787646956365,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11882-005-0067-z","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T01:24:15Z","timestamp":1180833855000},"page":"277-283","source":"Crossref","is-referenced-by-count":23,"title":["Mechanism of chronic urticaria exacerbation by aspirin"],"prefix":"10.1007","volume":"5","author":[{"given":"Lucyna","family":"Mastalerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Setkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"67_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2500\/108854190778879909","volume":"11","author":"GA Settipane","year":"1990","unstructured":"Settipane GA: Landmark commentary: history of aspirin intolerance. Allergy Proc 1990, 11:251\u2013251.","journal-title":"Allergy Proc"},{"key":"67_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1067\/mai.2003.1487","volume":"111","author":"A Szczeklik","year":"2003","unstructured":"Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003, 111:913\u2013921.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432\u2013436.","journal-title":"Eur Respir J"},{"key":"67_CR4","first-page":"472","volume":"89","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:472\u2013478.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"67_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","volume":"1","author":"A Szczeklik","year":"1975","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975, 1:67\u201369.","journal-title":"Br Med J"},{"key":"67_CR6","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-0348-8703-8","volume-title":"Novel Inhibitors of Leukotrienes","author":"G Folco","year":"1999","unstructured":"Folco G, Samuelsson B, Murphy RC: Novel Inhibitors of Leukotrienes. Basel-Boston: Birkhauser Verlag; 1999."},{"key":"67_CR7","doi-asserted-by":"publisher","first-page":"13926","DOI":"10.1073\/pnas.162468699","volume":"99","author":"NV Chandrasekharan","year":"2002","unstructured":"Chandrasekharan NV, Hu Dai, Lamar Turepu Roos K, et al.: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002, 99:13926\u201313931.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"67_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","volume":"60","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977, 60:276\u2013284.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","volume":"139","author":"A Zembowicz","year":"2003","unstructured":"Zembowicz A, Mastalerz L, Setkowicz M, et al.: Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiophatic urticaria with sensitivity to non-steroidial anti-inflammatory drugs. Arch Dermatol 2003, 139:1577\u20131582. COX-2 inhibitors do not induce urticaria in patients with CIU who are sensitive to aspirin. Aspirin-induced urticaria is associated with overproduction of cys-LTs.","journal-title":"Arch Dermatol"},{"key":"67_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1081-1206(10)62017-0","volume":"88","author":"E Nettis","year":"2002","unstructured":"Nettis E, Di PR, Ferrannini A, Tursi A: Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidial anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002, 88:331\u2013334. Rofecoxib, a COX-2 inhibitor, is a well-tolerated drug in patients with aspirin-induced urticaria, and it may represent a valid alternative drug in NSAID-sensitive patients.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"67_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","volume":"56","author":"SGO Johansson","year":"2001","unstructured":"Johansson SGO, Hourihane J, Bousquet J, et al.: A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813\u2013824. New classification of non-allergic drug hypersensitivity.","journal-title":"Allergy"},{"key":"67_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1081-1206(10)62221-1","volume":"87","author":"DD Stevenson","year":"2001","unstructured":"Stevenson DD, Sanchez-Borges M, Szczeklik A: Classfication of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenaze enzymes. Ann Allergy Asthma Immunol 2001, 87:1\u20134. Proposal of classification of allergic and pseudoallergic reactions to drugs that inhibit COX.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"67_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1046\/j.1365-2133.2001.04329.x","volume":"145","author":"S Harada","year":"2001","unstructured":"Harada S, Horikawa T, Ashida M, et al.: Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exerciseinduced anaphylaxis. Br J Dermatol 2001, 145:336\u2013339.","journal-title":"Br J Dermatol"},{"key":"67_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jaci.2003.12.323","volume":"113","author":"L Mastalerz","year":"2004","unstructured":"Mastalerz L, Setkowicz M, Sanak M, Szczeklik A: Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004, 113:771\u2013775. There are basic similarities between two distinct clinical syndromes. Clinical reactions after aspirin ingestion (either cutaneous or bronchial) are precipitated by drugs that inhibit COX-1, but not COX-2. Ingestion of aspirin leads to further, massive release of cys-LTs. Aspirin also releases PGD2 in both aspirin-sensitive asthmatics and in patients with CIU and history of NSAID intolerance.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR15","first-page":"24","volume":"61","author":"I Grzelewska-Rzymowska","year":"1993","unstructured":"Grzelewska-Rzymowska I, Szmidt M, Rozniecki J: Aspirinsensitive urticaria; clinical study. Pneumonol Alergol Pol 1993, 61:24\u201328.","journal-title":"Pneumonol Alergol Pol"},{"key":"67_CR16","first-page":"1","volume-title":"Urticaria\u2014Clinical, Diagnostic and Therapeutic Aspects","author":"BM Henz","year":"1998","unstructured":"Henz BM: The spectrum of urticaria. In Urticaria\u2014Clinical, Diagnostic and Therapeutic Aspects. Edited by Henz BM, Zuberbier T, Grabbe J, Monroe E. Berlin: Springer; 1998:1\u201317."},{"key":"67_CR17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.4.5574.262","volume":"4","author":"M Moore-Robinson","year":"1967","unstructured":"Moore-Robinson M, Warin RP: Effect of salicylates in urticaria. Br Med J 1967, 4:262\u2013264.","journal-title":"Br Med J"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1081-1206(10)62384-8","volume":"88","author":"R Asero","year":"2002","unstructured":"Asero R, Tedeschi A, Lorini M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann Allergy Asthma Immunol 2002, 88:468\u2013472. Some patients with NSAID hypersensitivity are characterized by the presence of circulating histamine-releasing factors. Their nature is still unclear.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"67_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","volume":"58","author":"W Aberer","year":"2003","unstructured":"Aberer W, Bircher A, Romano A, et al.: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854\u2013863. There is no in vitro test diagnosing aspirin intolerance. Aspirin hypersensitivity needs to be confirmed by aspirin provocation test.","journal-title":"Allergy"},{"key":"67_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","volume":"15","author":"E Nizankowska","year":"2000","unstructured":"Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000, 15:863\u2013869.","journal-title":"Eur Respir J"},{"key":"67_CR21","first-page":"1225","volume-title":"Allergy Principle and Practice","author":"DD Stevenson","year":"1998","unstructured":"Stevenson DD, Simon RA: Sensitivity to aspirin and nonsteroidal anti inflammatory drugs. In Allergy Principle and Practice. Edited by Middleton E, Reed CE, Adkinson NF, Yunginger JW, Busse WW. St Louis: Mosby; 1998:1225\u20131234."},{"key":"67_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/420135a","volume":"420","author":"NG Bazan","year":"2002","unstructured":"Bazan NG, Flower RJ: Lipid signals in pain control. Nature 2002, 420:136\u2013138.","journal-title":"Nature"},{"key":"67_CR23","volume-title":"Mast Cells and Basophils","author":"G Marone","year":"2000","unstructured":"Marone G, Lichtenstein LM, Galli SJ: Mast Cells and Basophils. San Diego: Academic Press; 2000."},{"key":"67_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaut.2003.09.007","volume":"22","author":"JM Pachlopnik","year":"2004","unstructured":"Pachlopnik JM, Horn MP, Fux M, et al.: Natural anti-FceRIalfa autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmunity 2004, 22:43\u201351. It is recognized that chronic urticaria in a subpopulation of patients appears to have an autoimmune basis.","journal-title":"J Autoimmunity"},{"key":"67_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","volume":"101","author":"M Ferrer","year":"1998","unstructured":"Ferrer M, Kinet JP, Kaplan AP: Comparative studies of functional and binding assays for IgG anti-Fc_RI _ (_-subunit) in chronic urticaria. J Allergy Clin Immunol 1998, 101:672\u2013676.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1067\/mai.2001.115484","volume":"107","author":"Y Kikuchi","year":"2001","unstructured":"Kikuchi Y, Kaplan AP: Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001, 107:1056\u20131062.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1113\/jphysiol.1938.sp003674","volume":"94","author":"W Felberg","year":"1938","unstructured":"Felberg W, Kellaway CH: Liberation of histamine and formation of lysolecithin-like substances by cobra venom. J Physiol 1938, 94:187\u2013226.","journal-title":"J Physiol"},{"key":"67_CR28","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.76.9.4275","volume":"76","author":"RC Murphy","year":"1979","unstructured":"Murphy RC, Hammarstrom S, Samuelsson B: Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A 1979, 76:4275\u20134279.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"67_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199009063231006","volume":"323","author":"RA Lewis","year":"1990","unstructured":"Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5 lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990, 323:645\u2013655.","journal-title":"N Engl J Med"},{"key":"67_CR30","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0006-2952(96)00819-2","volume":"53","author":"A Sala","year":"1997","unstructured":"Sala A, Folco G, Henson PM, Murphy RC: Pharmacological modulation of human platelet leukotriene C synthase. Biochem Pharmacol 1997, 53:905\u2013908.","journal-title":"Biochem Pharmacol"},{"key":"67_CR31","doi-asserted-by":"publisher","first-page":"22934","DOI":"10.1074\/jbc.272.36.22934","volume":"272","author":"PJ Jakobsson","year":"1997","unstructured":"Jakobsson PJ, Mancini JA, Riendeau D, Ford-Hutchinson AW: Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activity. Biol Chem 1997, 272:22934\u201322939.","journal-title":"Biol Chem"},{"key":"67_CR32","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1046\/j.1365-2222.2000.00953.x","volume":"30","author":"M Pierzchalska","year":"2000","unstructured":"Pierzchalska M, Mastalerz L, Sanak M, et al.: A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leukocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy 2000, 30:1785\u20131791.","journal-title":"Clin Exp Allergy"},{"key":"67_CR33","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1046\/j.1365-2222.2001.01074.x","volume":"31","author":"G Celik","year":"2001","unstructured":"Celik G, Bavbek S, Misirligil Z, Melli M: Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripherial blood leucocytes in aspirin-induced asthmatic patients. Clin Exp Allergy 2001, 31:1615\u20131622.","journal-title":"Clin Exp Allergy"},{"key":"67_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(95)90409-3","volume":"345","author":"ID Pavord","year":"1995","unstructured":"Pavord ID, Tattersfield AE: Bronchoprotective role for endogenous prostaglandin E2. Lancet 1995, 345:436\u2013438.","journal-title":"Lancet"},{"key":"67_CR35","doi-asserted-by":"publisher","first-page":"11356","DOI":"10.1074\/jbc.271.19.11356","volume":"271","author":"JF Penrose","year":"1996","unstructured":"Penrose JF, Spector J, Baldasaro M, et al.: Molecular cloning for human LTC4 synthase: organization, nucleotide sequence and chromosomal localization to 5q35. J Biol Chem 1996, 271:11356\u201311361.","journal-title":"J Biol Chem"},{"key":"67_CR36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/S0140-6736(05)64015-9","volume":"350","author":"M Sanak","year":"1997","unstructured":"Sanak M, Simon HU, Szczeklik A: Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997, 350:1599\u20131600.","journal-title":"Lancet"},{"key":"67_CR37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1165\/ajrcmb.23.3.4051","volume":"23","author":"M Sanak","year":"2000","unstructured":"Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A: Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000, 23:290\u2013296.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"67_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1067\/mai.2000.107603","volume":"106","author":"R Van Sambeek","year":"2000","unstructured":"Van Sambeek R, Stevenson D, Baldasaro M, et al.: 5\u2019Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant phenotype in the United States. J Allergy Clin Immunol 2000, 106:72\u201376.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/thorax.55.suppl_2.S28","volume":"55","author":"AP Sampson","year":"2000","unstructured":"Sampson AP, Siddiqui S, Buchanan D, et al.: Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000, 55:528\u2013531.","journal-title":"Thorax"},{"key":"67_CR40","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1046\/j.1365-2362.2002.01088.x","volume":"32","author":"L Mastalerz","year":"2002","unstructured":"Mastalerz L, Nizankowska E, Sanak M, et al.: Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. Eur J Clin Invest 2002, 32:949\u2013955.","journal-title":"Eur J Clin Invest"},{"key":"67_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/thorax.55.suppl_2.S70","volume":"55","author":"B Wedi","year":"2000","unstructured":"Wedi B, Kapp A: Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax 2000, 55:570\u2013571.","journal-title":"Thorax"},{"key":"67_CR42","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1365-2222.2004.02050.x","volume":"34","author":"P Gamboa","year":"2004","unstructured":"Gamboa P, Sanz ML, Caballero R, et al.: The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004, 34:1448\u20131457.","journal-title":"Clin Exp Allergy"},{"key":"67_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0091-6749(77)90067-7","volume":"60","author":"T Okazaki","year":"1977","unstructured":"Okazaki T, Ilea VS, Rosario NA: Regulatory role of prostaglandin E in allergic histamine release with observation on the responsiveness of basophil leucocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol 1977, 60:360\u2013366.","journal-title":"J Allergy Clin Immunol"},{"key":"67_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","volume":"80","author":"NA Soter","year":"1983","unstructured":"Soter NA, Lewis RA, Corey EJ, Austen KF: Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Investig Dermatol 1983, 80:115\u2013119.","journal-title":"J Investig Dermatol"},{"key":"67_CR45","first-page":"357","volume":"61","author":"I Grzelewska-Rzymowska","year":"1993","unstructured":"Grzelewska-Rzymowska I: Chemotactic activity of serum granulocytes after aspirin with aspirin-sensitive urticaria who find themselves in a state of tolerance for this drug. Pneumonol Alergol Pol 1993, 61:357\u2013361.","journal-title":"Pneumonol Alergol Pol"},{"key":"67_CR46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1081-1206(10)63166-3","volume":"82","author":"R Asero","year":"1999","unstructured":"Asero R: Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol 1999, 82:554\u2013558.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"67_CR47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B Dahl\u00e9n","year":"1998","unstructured":"Dahl\u00e9n B, Nizankowska E, Szczeklik A, et al.: Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998, 157:1187\u20131194.","journal-title":"Am J Respir Crit Care Med"},{"key":"67_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/21658","volume":"399","author":"KR Lynch","year":"1999","unstructured":"Lynch KR, O\u2019Neill GP, Liu Q, et al.: Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999, 399:789\u2013793.","journal-title":"Nature"},{"key":"67_CR49","doi-asserted-by":"publisher","first-page":"30531","DOI":"10.1074\/jbc.M003490200","volume":"275","author":"CE Heise","year":"2000","unstructured":"Heise CE, O\u2019Dowd BF, Figueroa DJ, et al.: Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000, 275:30531\u201330536.","journal-title":"J Biol Chem"},{"key":"67_CR50","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","volume":"31","author":"ML Pacor","year":"2001","unstructured":"Pacor ML, Di Loranzo G, Corrocher R: Efficacy of leukotriene receptor antagonist in chronic urticaria: a double blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria and intolerance to food additives and\/or acetylsalicylic acid. Clin Exp Allergy 2001, 31:1607\u20131614. Aspirin-induced urticaria patients seem to benefit more from leukotriene receptor antagonists than patients who tolerate aspirin well.","journal-title":"Clin Exp Allergy"},{"key":"67_CR51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1067\/mai.2002.126676","volume":"110","author":"Z Zerbagci","year":"2002","unstructured":"Zerbagci Z: The leukotriene receptor antagonist montelukast in the treatment of chronic urticaria: a single-blind, placebocontrolled, crossover clinical study. J Allergy Clin Immunol 2002, 110:484\u2013488.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-005-0067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0067-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:30:06Z","timestamp":1652614206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-005-0067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s11882-005-0067-z","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}